treatment | CARLAT PUBLISHING

When Bipolar and ADHD Overlap: Treatment 2

December 2, 2024

Kellie Newsome, PMHNP and Chris Aiken, MD

How to treat ADHD in bipolar disorder without destabilizing mood part 1: stimulants and non-stimulants.

When Bipolar and ADHD Overlap: Treatment 1

November 25, 2024

Kellie Newsome, PMHNP and Chris Aiken, MD

How to treat ADHD in bipolar disorder without destabilizing mood part 1: stimulants and non-stimulants.

Research Update

Stimulants in Preschool-Age Children

October 1, 2024

Earth Hasassri, MD

Earth Hasassri, MD. Dr. Hasassri has no financial relationships with companies related to this material.

We are understandably hesitant to treat young children with medication for ADHD. Does it work? Will there be worse or different side effects? This research update will help you weigh the risks and benefits of pursuing stimulant treatment for ADHD in our smallest patients.

Expert Q&A

Treating ADHD in Young Children

October 1, 2024

Natalie Pon, MD

Natalie Pon, MD

Child and adolescent psychiatrist, Children’s Health Council; adjunct clinical faculty, Stanford University, Palo Alto, CA.

Dr. Pon has no financial relationships with companies related to this material.

What does ADHD look like in young children? How do we differentiate it from just another active toddler? And if a young child really does have ADHD, how do we treat it? Our interview with Dr. Natalie Pon will help you identify and treat ADHD in young children.

Clinical Update

Dysregulation in Autism: Irritability, Aggression, and “Pathological Demand Avoidance”

October 1, 2024

Alyssa Aikman, MSN, APRN, PMHNP-BC

Alyssa Aikman, MSN, APRN, PMHNP-BC. Psychiatric nurse practitioner in outpatient group practice, Vancouver, WA.

Ms. Aikman has no financial relationships with companies related to this material.

Pathological demand avoidance (PDA) is a popular concern among autistic kids and families. It’s not in the DSM, yet we need to understand and address it. This clinical update helps you approach irritability and PDA rationally to help autistic patients connect and regulate before merely prescribing D2-blocking antipsychotics.

PTSD 101: Nine Off-Label Meds

September 23, 2024

Chris Aiken, MD and Kellie Newsome, PMHNP

A new medication is knocking on the door for FDA approval in PTSD, and it isn’t MDMA. We cover that, and 8 other off label medications.

CLINICAL UPDATE

The Psychotherapy of Avoidant Personalities: A Basic Overview

July 11, 2024

Mark L. Ruffalo, MSW, DPsa

Mark L. Ruffalo, MSW, DPsa. Editor in Chief, The Carlat Psychotherapy Report, psychotherapist in private practice in Tampa, Florida, and Assistant Professor of Psychiatry at the University of Central Florida College of Medicine and Adjunct Instructor of Psychiatry at Tufts University School of Medicine. He has broad clinical experience in the psychoanalytic treatment of mood, personality, and psychosomatic disorders, and has particular interest in the psychotherapy of schizophrenia and borderline personality disorder.

Dr. Ruffalo has no financial relationships with companies related to this material.

The characteristics, differential diagnosis, theoretical considerations, and treatment approaches for avoidant personality disorder (AvPD), including insights into its prevalence and cultural considerations.

Clinical Update

Addressing Social Isolation and Loneliness in Children and Teens

July 1, 2024

Aydar Shaildayev, MD and Eric Whitney, MD

Aydar Shaildayev, MD. Psychiatry resident, NYU Langone, New York, NY.

Eric Whitney, MD. Clinical assistant professor, Department of Child and Adolescent Psychiatry, NYU Grossman School of Medicine, New York, NY.

Drs. Shaildayev and Whitney have no financial relationships with companies related to this material.

The Surgeon General has put out a call to address loneliness and social isolation. But what do we do about it? This clinical update will help you define loneliness and social isolation, assess for them, and help lonely or isolated kids and teens.

Contingency Management with Dr. Dominick DePhilippis

June 3, 2024

Noah Capurso, MD

In today's episode, Dr. DePhilippis tells us all about Contingency Management: what it is, how it works, and its evidence for the treatment of stimulant use disorders.